Treace Medical presents 5-year ALIGN3D study showing Lapiplasty bunion procedure recurrence as low as 0.8%

• Treace Medical Concepts announced new long-term and interim clinical results for its Lapiplasty, Adductoplasty, and SpeedPlate platforms.
• Findings will be presented at the American Orthopaedic Foot & Ankle Society annual meeting in Seattle.
• The 5-year Lapiplasty study showed durable correction with low recurrence, supporting claims of sustained outcomes versus traditional bunion surgery.
• A 2-year combined Adductoplasty-Lapiplasty analysis indicated maintained alignment improvements with reduced pain and better patient-reported function.
• A 1-year SpeedPlate study reported strong fusion healing outcomes, reinforcing the case for earlier weight-bearing protocols.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Treace Medical Concepts Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609171716PRIMZONEFULLFEED9829261) on September 17, 2026, and is solely responsible for the information contained therein.